The 2026 acne trial protocol tests oral HEXBIO probiotic granules and topical secretome serum alongside standard therapy, according to the ClinicalTrials registry mirror. It randomizes 64 adults with mild-to-moderate acne to four treatment arms for eight weeks.
An oral probiotic means live bacteria taken by mouth to affect gut and skin balance. A topical secretome means a serum made from factors released by mesenchymal stem cells, applied to skin. The linked protocol publication describes HEXBIO granules with six Lactobacillus and Bifidobacterium strains plus the secretome serum, reports BMJ Open.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the four treatment arms test
- Who the protocol is for
- Which skin reactions deserve direct questions
- What earlier probiotic safety results show
- Safety questions to ask at screening
What the four treatment arms test
The Phase 2 double-blind trial is sponsored by Universitas Padjadjaran. Patients receive standard therapy plus oral probiotic, topical secretome, both actives, or both placebos. The design isolates the added effect of each active part.
Outcomes include acne lesion counts, skin microbiome, sebum, pH, moisture, collagen and IL-6, a marker of inflammation. That mix lets researchers link visible clearing to barrier, oil, bacterial and inflammatory changes. The registry lists the eight-week treatment period for all four arms.
Who the protocol is for
The protocol focuses on adults with persistent facial acne. Eligibility requires a certified-dermatologist diagnosis of mild-to-moderate acne vulgaris with new lesions recurring during the prior six months.
The trial is conducted in the dermatology department at Bali Mandara Hospital, according to the Veeva study record. Adults can check fit with these points:.
- facial acne rated mild-to-moderate by a dermatologist
- breakouts that keep returning over six months
- ability to attend hospital visits for eight weeks
- willingness to follow rules on other acne products
Which skin reactions deserve direct questions
Standard therapy often includes benzoyl peroxide or adapalene, which can cause redness, peeling, dryness and stinging. Ask how the trial separates that expected irritation from a reaction to the secretome serum. Ask whether patch testing is done before full-face use.
Topical exosome and secretome reviews report mainly mild, short-lived redness, swelling or edema, with no serious long-term signal for topical use. Injection reports differ sharply and include delayed granulomas, anaphylaxis and one necrosis case after dermal lyophilized-exosome injection, reports the Journal of Cosmetic Dermatology case review. Adults using only the serum do not face the same needle risks, but should still ask how redness and swelling are graded and treated.
What earlier probiotic safety results show
A 2025 systematic review pooled three double-blind trials with 231 patients. Oral probiotics modestly reduced inflammatory acne severity with favorable short-term safety, but data on rare or long-term harms were thin and certainty was low to moderate, reports Medicina. That pattern supports close symptom tracking rather than alarm.
One 12-week trial in ages 12 to 30 used Lacticaseibacillus rhamnosus CECT 30031 plus Arthrospira platensis. Acne Global Severity Scale improvement occurred in 20 of 40 probiotic patients versus 10 of 34 placebo patients, with fewer noninflammatory lesions. Ask about stomach upset, bloating, loose stools and allergy symptoms, since gut effects are the most practical probiotic concern.
Safety questions to ask at screening
Regulators still treat exosome products with caution for disease claims. There are currently no FDA-approved exosome products, and exosomes used to treat human disease need premarket review as drugs and biological products, states the FDA safety notice.
Ask whether the study serum is an approved trial product with ethics approval and adverse-event reporting. Bring these checks to the visit: Bring your full product list and allergy history to the screening visit.
- antibiotic or probiotic washout rules before and during the trial
- pregnancy, breastfeeding, immunosuppression and allergy history
- current benzoyl peroxide, adapalene, acids and exfoliants
- patch-test plan and daily rules for redness, swelling, dryness or gut upset
You Might Also Like
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Safety and Skin-Reaction Questions for Adults With Persistent Acne
- Why the 2026 Probiotic and Secretome Paper Reports No Trial Results Yet: How Adults With Persistent Acne Can Compare Probiotic Claims
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: Safety and Skin-Reaction Questions for Adults With Persistent Acne